Welcome & Introduction

LD SCLC- Radiation

LD SCLC- Concurrent Chemotherapy

LD SCLC- Neoadjuvant

ED- Selection Of First Line Chemotherapy

Selection Of Regimen- Poor PS & SVCO

ED- SCLC - Selection of Immunotherapy

ED- Selection Of The Second Line And Beyond

Interpretation Of KRAS Mutation

Selection Of 1st Line Therapy For KRAS

Mechanism Of Resistance To KRAS TKI And Therapy Post Resistance

Evaluation Of BRAF Mutation Testing Methodology: Technologies & Their Interpretation

Selection Of 1st Line Targeted Therapy For BRAF Mutated NSCLC

Mechanism Of Resistance To BRAF TKI And Therapy Post Resistance In BRAF Mutated NSCLC

Interpretation Of NTRK Mutation

Selection Of 1st Line Therapy For NTRK

Mechanism Of Resistance To NTRK TKI And Therapy Post Resistance

Interpretation Of RET Mutation

Selection Of 1st Line Therapy For RET

Mechanism Of Resistance To RET TKI And Therapy Post Resistance

Interpretation Of Exon 20 Insertion

Selection Of 1st Line Therapy For EXON 20 Insertion

Mechanism Of Resistance To EXON 20 Insertion TKI And Therapy Post Resistance

Closing Remarks

Launch of www.crsf.in Website